Owners of the parent 27.96 8.19% 41.21 34.30% (13.25) (32.15%) Jan – Mar 63 Jan – Mar 62 Increase/(Decrease) DOD BIOTECH PUBLIC COMPANY LIMITED เลขท ี111 หมู่ท ี2 ตําบลท่าจีน อําเภอเมืองสมุทรสาคร จังหวดั
electricity were THB 176 million in the second quarter of 2020, which increased by THB 90 million or 105% from the same period last year. The increase was mainly because the Company recognized RH’s and AVA’s
occur from several projects and backlogs of IGE and subsidiaries. The contracts of the projects have been postponed and made the revenue recognition is not on schedule. 2. Sales and Services increase from
slowdown of investment environment throughout the country. Cost of goods sold and services decreased in portion of decreasing revenue but expenses were increase at the same level as last year and interest
profit (loss) The company recorded net loss of 19.05 million Baht in the third quarter of 2019, increase of 17.20 million Baht compared with net profit of 1.85 million Baht in the same quarter last year
attributable to owner of the Company 1,364.84 1,680.53 (315.69) (18.8) 5,058.41 4,938.99 119.42 2.4 * excluding fuel cost Increase (Decrease ) % Increase (Decrease ) % Quarter 3 Quarter 1-3 The operating result
Ramnakara Co.,Ltd.'s capital increase shares and status change from Associated to Subsidiary. 09/06/2022 17:01 The acquisition of investment in Vachara Sirivej Co.,Ltd. (Chiangrai Inter Hospital) 07/06/2022
while during 2020 the discount was deducted from depreciation expenses • EBITDA margin increased by 5.3% in Q2/2021 and 4.6% in 1H/2021. The increase of EBITDA margin was mainly due to the Company’s
2022 1st quarter 2022 2nd quarter 2021 % Increase (Decrease) Six-month period % YoY QoQ 2022 2021 Revenue from sales and services 2,106.71 2,351.40 1,404.30 50.02% (10.41%) 4,458.11 2,859.55 55.90% Cost
regarding the proposal for shareholders’ approval of capital increase supporting documents to the SEC within 17 January 2024 and disclose the information through the SET Electronic Listed Companies